Basket cover image
14 handpicked stocks

Made in the UK

Diversify your portfolio with some of Britain's most established companies. Our analysts have carefully selected these UK powerhouses that span multiple industries from banking to pharmaceuticals, energy to consumer goods.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+4

Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at mai 10

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

AZN

AstraZeneca PLC

AZN

Current price

$79.54

SHEL

SHELL PLC - ADS

SHEL

Current price

$71.45

HSBC

HSBC Holdings plc

HSBC

Current price

$63.84

About This Group of Stocks

1

Our Expert Thinking

The UK represents the world's sixth-largest economy with London as a leading financial hub. These stocks offer a strategic mix of defensive and cyclical investments across diverse sectors like pharmaceuticals, energy, finance, and consumer goods, providing both stability and growth potential.

2

What You Need to Know

This collection features multinational corporations with global presence and influence, underpinned by the UK's strong regulatory framework. Many of these companies offer consistent dividends and represent traditional strength combined with innovative approaches to changing markets.

3

Why These Stocks

These companies were selected for their market leadership, proven resilience, and international reach. From pharmaceutical giant AstraZeneca to energy leaders Shell and BP, these stocks represent Britain's economic strength while offering exposure to various sectors of the global economy.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+0.95%

Group Performance Snapshot

0.95%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 0.95% over the next year.

11 of 14

Stocks Rated Buy by Analysts

11 of 14 assets in this group are rated Buy by professional analysts.

4%

Group Growth

This group averaged a 4% return last month.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

🌍

Global Influence

These UK giants have worldwide reach and operations. Companies like HSBC, Shell, and AstraZeneca are household names globally, letting you tap into international markets through British expertise.

💷

Dividend Powerhouses

Many British companies have long histories of paying consistent dividends. Stocks like British American Tobacco and Diageo are known for rewarding shareholders with regular income alongside potential growth.

🏆

Fortune 500 Prestige

The UK is home to 17 companies on the Fortune Global 500 list. Investing in these market leaders means owning a piece of businesses that shape entire industries and economies worldwide.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

🚀

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

The New Cost of Compliance: Investing in HR Tech

The New Cost of Compliance: Investing in HR Tech

Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.

View stocks
GLP-1s Target Liver Disease

GLP-1s Target Liver Disease

The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.

View stocks
Pharma's Digital Prescription

Pharma's Digital Prescription

Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.

View stocks
View All

Frequently Asked Questions

Everything you need to know about the product and billing.